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Abstract
The reprogramming of human somatic cells to induced pluripotent stem (hiPS) cells enables the possibility of generating
patient-specific autologous cells for regenerative medicine. A number of human somatic cell types have been reported to
generate hiPS cells, including fibroblasts, keratinocytes and peripheral blood cells, with variable reprogramming efficiencies
and kinetics. Here,weshowthathumanastrocytescanalso bereprogrammedintohiPS (ASThiPS)cells,withsimilarefficiencies
to keratinocytes, which are currently reported to have one of the highest somatic reprogramming efficiencies. ASThiPS lines
were indistinguishable from human embryonic stem (ES) cells based on the expression of pluripotent markers and the ability
to differentiate into the three embryonic germ layers in vitro by embryoid body generation and in vivo by teratoma formation
after injection into immunodeficient mice. Our data demonstrates that a human differentiated neural cell type can be
reprogrammed to pluripotency and is consistent with the universality of the somatic reprogramming procedure.
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Introduction
The developmentally committed identity of somatic cells can be
reverted to a pluripotent state through different reprogramming
approaches. Among these methodologies, pluripotency is achieved
by somatic cell nuclear transfer into enucleated unfertilized oocytes,
cell fusion of differentiated cells with embryonic stem (ES) cells or
treatment of differentiated cells with extracts derived from
pluripotent cells [reviewed in 1]. More recently, it has been reported
thattheinductionofpluripotencyinsomaticcellscan be achieved by
the expression of defined transcription factors [2–6], including either
the combination of Oct4, Sox2, Klf4 and cMyc [2–5], although the
latter was found to be dispensable [7], or Oct4, Sox2, Nanog and
Lin28 [6]. Induced pluripotent stem (iPS) cells are epigenetically and
functionally similar to ES cells [2–6], although studies comparing ES
and iPS cells continue to more precisely examine the equivalence of
these cell types. While the molecular mechanisms underlying the
process of reprogramming remain obscure, recent reports indicate
that classical hallmarks of malignancy such as inactivation of the p53
pathway [8–10] or silencing of the ink4/arf locus [11] leading to
immortalization [12] are shared between somatic cell reprogram-
ming and cell transformation.
In the last few years, rapid progress has been made towards
improving the efficiency of iPS cell generation, development of
integration-free strategies or substitution of some reprogramming
factors with other proteins or chemical compounds [13–17].
Though initial reports relied on the use of retroviral or lentiviral
delivery systems to introduce the reprogramming transcription
factors [2–6], induction of pluripotency can now be achieved with
plasmid transfection [13], non-integrative episomal vectors [14],
Piggy-Bac transposition [15], self-excisable vectors [16] or by the
delivery of reprogramming proteins [17]. The universality of the
process has been demonstrated by the generation of iPS cells from
different species [18–20], as well as from different sources of
somatic cells including fibroblasts [2], CD34+ cells [21], adipose
cells [22], HUVEC cells [23], keratinocytes [24], neural stem cells
[25] or hepatocytes [26].
Here, we report the generation of iPS cells from human astrocytes
(ASThiPS) with a similar efficiency to keratinocytes, one of the
human somatic cell types with the highest reported reprogramming
efficiency to date. ASThiPS cells show a pluripotent gene expression
signature, display an ES-like cell cycle profile, differentiate into the
three germ layers in vitro and in vivo, and generate multiple neuronal
cell lineages following directed differentiation.
Results
Astrocytes can be reprogrammed to pluripotency with
high efficiency
We investigated the potential of human astrocytes to reprogram
into hiPS cells following retroviral transduction with Oct4, Sox2,
Klf4 and cMyc (OSKC) transcription factors (Figure 1). We also
included a retrovirus encoding GFP to evaluate the efficiency of
transduction and visualize exogenous transgene silencing [2–6].
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15526Similar reprogramming experiments were carried out in parallel
with human keratinocytes, a somatic cell with a high reprogram-
ming efficiency [24] and fibroblasts, a cell type with significantly
lower reprogramming efficiency [24]. Two serial spinfections of
keratinocyte, fibroblast or astrocyte cultures resulted in over 90%,
50% and 40% of infected cells, respectively (Figure 1A, left column
and data not shown). To evaluate the efficiency of reprogramming,
identical numbers of GFP
+ cells were plated onto mouse
embryonic fibroblasts (MEFs). Twelve days after the first infection,
we started to observe the appearance of morphological hES-like
colonies, coinciding with transgene silencing (Figure 1A, second
column). However, we also detected partially reprogrammed
colonies with non-hES morphological phenotypes, where trans-
gene silencing, based on GFP expression, did not occur (Figure 1A,
third column). Finally, eighteen days following the initial infection,
we either fixed/stained or manually picked the hiPS cell colonies
obtained for further culture and characterization (Figure 1A, right
column). Reprogramming efficiency was defined as the number of
Nanog positive colonies per 10000 GFP
+ cells seeded on MEFs.
We observed a similar reprogramming efficiency for human
astrocytes and keratinocytes, which was much higher when
compared to fibroblasts (Figure 1B). Similar reprogramming
experiments performed using alkaline phosphatase staining to
evaluate pluripotent colony formation showed comparable results
(data not shown). To better understand why astrocytes reprogram
more efficiently than other cell types such as fibroblasts, we
performed a real-time analysis of the expression of genes involved
in different aspects of stem cell biology (for a complete description
see Material and Methods and Table S1, which contains the total
list of genes analyzed) in the H9 hES cell line, astrocytes,
keratinocytes and fibroblasts. Using a Pearson correlation as a
distance measure between the different sets of values we observed
that both, keratinocytes and astrocytes, are closer than fibroblasts
to hES cells (Figure 1C), which may contribute to the higher
reprogramming efficiency of astrocytes.
Characterization of ASThiPS cell lines
We manually picked several colonies of hiPS cells derived from
astrocytes (ASThiPS) and established three independent lines for
further analysis (Figure 2A). All ASThiPS cell lines showed
permanent silencing of the reprogramming transgenes, and
displayed expression levels of the endogenous reprogramming
Figure 1. Highly efficient somatic cell reprogramming from astrocytes. (A) Morphological changes and GFP expression in OSKC-infected
astrocytes during the reprogramming process at 1 (first column), 12 (second and third columns) and 18 (fourth column) days after the initial infection.
Note the efficient GFP silencing in cells with hES cell-like morphology (second column) versus transformed non-hES cell morphology cells (third
column). Scale bar: 50 mM. (B) Absolute reprogramming efficiencies, observed for astrocytes (two different sources of astrocytes were used as
indicated), fibroblasts and keratinocytes, normalized to the number of GFP positive cells seeded, (left graph). A representative example of Nanog-
stained colonies is shown in the right panels. Uninfected cells were used as a negative control for all experiments (data not shown). n=number of
independent experiments with 3 biological replicates each. All error bars depict the SEM. (C) Graphical representation of the Ct values normalized to
the expression of the GAPDH housekeeping gene between the different groups of values in the noted samples. r=Pearson coefficient.
doi:10.1371/journal.pone.0015526.g001
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shown; for a complete description of the primers used, see Table
S2). Moreover, the expression of several stem cell markers such as
Nanog, Utf1, Dppa4, or Zfp42, was indistinguishable from hES
cells (Figure 2A, for a complete description of the primers used, see
Table S2). We also analyzed several pluripotency markers at the
protein level by immunoblotting (Figure 2B; for a complete
description of the antibodies used, see Table S3) and immunoflu-
orescence (Figure 2C, Table S3), and validated that all ASThiPS
cell lines resembled hES cells in terms of pluripotent gene
expression. ASThiPS cell lines were maintained for at least 20
passages without a loss of pluripotency and all stained positive for
alkaline phosphatase (AP) activity (Figure 2C and data not shown).
hES cells have a cell cycle signature structure characterized by a
very short G1 phase and a high percentage of cellsin S phase [27]. We
found that the characteristic stem cell cycle signature of hES cells is
acquired in all the ASThiPS cell lines and differs greatly from the cell
cycle profile observed in the cells of origin (Figure 3A). Consequently,
we observed a dramatic change in the expression profile of the cell
cycle proteins involved in the G1/S transition in the ASThiPS cell
lines to levels similar to those observed in hES cells (Figure 3B).
Finally,thepluripotencyofeachASThiPScelllinewasassessedby
differentiation into the three embryonic germ layers in vitro, using
embryoid body (EB) formation (Figure 4A and B), and in vivo, by
teratoma formation (Figure 4C). Immunofluorescence analysis
(Figure 4A) and real-time PCR analysis of ectodermal, endodermal
and mesodermal markers following EB differentiation demonstrated
that ASThiPS cells have the ability to generate all three embryonic
germ layers in vitro (Figure 4A and B). Similarly, injection of
ASThiPS cell lines into nude mice resulted in the formation of
teratomas containing tissues derived from all three embryonic germ
layers(Figure4D).Finally,karyotypeanalysisrevealedthatASThiPS
celllines had normal chromosomal integrity(Figure 4C). Thus, these
combined findings demonstrate that ASThiPS cells are pluripotent.
ASTiPS cell lines differentiate into different neural cell
types
To assess the potential of ASThiPS cell lines to differentiate into
neural lineages, we adopted a step-wise in vitro neural differentiation
protocol routinely used with hES cells [28] to the ASThiPS cell lines
and thereby generated ASThiPS-derived neural progenitor cells
(NPCs). NPCs express Nestin and Sox2 and are capable of
Figure 2. ASThiPS cell lines express pluripotent markers. (A and B) Analysis of the ASThiPS cells lines showing the relative expression of the
endogenous levels for the annotated genes by real-time PCR (A) or the total Oct4, Sox2, and Nanog protein levels by western blot (B) compared to
hES cells and the somatic cells of origin. The relative gene expression levels of Klf4 and c-Myc are represented in linear scale, whereas those for the
rest of genes are represented in log scale. Data are shown as the relative averages 6 SEM calculated from two biological replicates analyzed in
triplicate. (C) Immunofluorescence analysis of the indicated pluripotent markers in the different ASThiPS cell lines. DAPI was used to visualize nuclei.
Alkaline phosphatase (AP)-staining was also performed for each of the ASThiPS cell lines. Scale bar: 50 mM.
doi:10.1371/journal.pone.0015526.g002
Figure 3. ASThiPS cells acquired the stem cell cycle signature observed in hES cells. (A) BrdU incorporation analyzed by flow cytometry in
ASThiPS cell lines, astrocytes and H9 cells. Represented in each dot plot are the percentages of cells in G1 phase (population in the lower left corner),
S phase (upper region) and G2 phase (population in the lower right corner). 10,000 cells were represented in each dot plot and the averages 6 SEM
were calculated from two biological replicates analyzed in triplicate. (B) Analysis of the indicated cell cycle genes, by real-time PCR in ASThiPS cell
lines, the parental cells of origin and hES cells. Data in are shown as relative average fold change 6 SEM from two biological replicates analyzed in
triplicate.
doi:10.1371/journal.pone.0015526.g003
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Neurons express markers such as bIII-tubulin and MAP2ab: bIII-
tubulinisregardedasaneuron-specificmarkeranditsexpressionhas
been suggested to be one of the earliest markers to signal neuronal
commitment in primitive neuroepithelium [30], while MAP2ab is a
neuron-specific microtubule-associated protein, the expression of
which is restricted to dendrites during neuronal maturation [31].
Glial Fibrillary Acidic Protein (GFAP) is a 50 kDa intracytoplasmic
filamentous protein that constitutes a portion of the cytoskeleton in
astrocytes and is the most specific marker for cells of astrocytic origin
[32]. ASThiPS-derived NPCs express Nestin and Sox2, ASThiPS-
derived neurons express both bIII-tubulin and MAP2ab, and
ASThiPS-derived astrocytes express GFAP but not bIII-tubulin
(Figure 5). These data confirmed the ability of ASThiPS cells to
generate mature differentiated cells of neural origin.
Discussion
The induction of pluripotency by expression of Oct4, Sox2, Klf4
and c-Myc has been reported in human somatic cells of different
origin [2,21–26]. Recently, the generation of iPS cells from human
neural stem cells has been achieved with only the expression of Oct4
[25].Thesedata suggestthatthe highsimilarityinthetranscriptional
program reported between these committed stem cells and hES cells
helps to facilitate the reprogramming process [25]. In our work, we
demonstrated the ability to generate hiPS cells from a differentiated
neural cell type. Furthermore, we showed that human astrocytes
generated hiPS (ASThiPS) with a reprogramming efficiency similar
to human keratinocytes, which is much higher than the efficiency
observed for other cell types, such as fibroblasts (Figure 1). This
might be due to the fact that astrocytes or keratinocytes are cell types
closer to hES cells in terms of gene expression of human stem cell-
related genes (Figure 1). ASThiPS cell lines expressed endogenous
pluripotent markers (Figure 2), acquired the stem cell cycle signature
of human ES cells (Figure 3), differentiated in vitro and in vivo into the
three embryonic germ layers and displayed a normal karyotype
(Figure 4). We also demonstrated the ability of the ASThiPS cell
lines, using a neural directed differentiation protocol in vitro,t o
differentiate into neural lineages (i.e. neurons and astrocytes).
Figure 4. ASThiPS cell lines differentiate into the three embryonic germ layers. (A–B) Embryoid bodies were derived from ASThiPS cell lines or
H9 cells maintained on MEFs, and were either collected following the initial formation (EB day 0) or following differentiation for 15 days in EB media (EB
day 15). Immunofluorescence (A) and real-time PCR analysis (B) were performed for specific differentiation markers from the three embryonic germ layers
as defined by the expression of mesodermal (Msx1, Smooth muscle actin (SMA)), trophectodermal (Cdx2), ectodermal (Pax6, bIIITubulin, FGF5) and
endodermal (GATA4, GATA6,AFP,Albumin and FoxA2). For immuofluorescences, DAPI was usedtovisualize the nuclei (A).Scale bar: 50 mM.For real-time
PCR, dataare shown asrelative average fold changes6 SEM from two biologicalreplicates analyzed intriplicate(B).Expressionofthe pluripotent markers
Oct4 and Nanog was assessed as a control for efficient differentiation (B). (C) G-banding karyotype analysis reveals a normal karyotype of the noted
ASThiPScelllines.Thepassagenumberatwhichthekaryotypewasanalyzedisindicatedinthefigure.(D)Teratomaformationwasassessedbyinjectionof
theASThiPScellsintothetestesorkidneyofSCIDmice.Immunofluorescenceanalysisdemonstratetheexistenceofthethreemainembryonic germlayers
as defined by the expression of specific endodermal (AFP (a-fetoprotein), and FoxA2), ectodermal (bIIITubulin and GFAP) and mesodermal (ASMA (alpha-
smooth muscle actin) and ASA (alpha sarcomeric actin) markers. All images were obtained from the same tumor. Scale bar: 50 mM.
doi:10.1371/journal.pone.0015526.g004
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transition (MET) and therefore, the consequent activation of an
epithelial program, is an essential step in the successful reprogram-
ming of fibroblasts, a mesenchymal cell-type [33,34]. It is tempting
to speculate that this contributes to the fact that keratinocytes and
astrocytes, both epithelial-cell types, show higher reprogramming
efficiencies compared to other cell types of a different origin. A
detailed analysis of the reprogramming process occurring in cells
of different embryonic origins might unravel the mechanisms
driving the acquisition of pluripotency.
Finally, in order to apply iPS cell technology to regenerative
medicine, the reprogramming process must be better understood.
Towards this end, there is a need for highly efficient sources of
somatic cells with which to study this process. The finding that
astrocytes can be reprogrammed with high efficiency may assist in
achieving this aim.
Materials and Methods
hES cell culture and differentiation
Human H9 (WA09) and H1 (WA01) embryonic stem cell lines
were obtained from WiCell Research Institute and maintained on
mitotically inactive mouse embryonic fibroblast (MEF, Millopore)
feeder layers in hES cell medium: DMEM/F12 (Invitrogen)
supplemented with 20% Knockout Serum Replacement (Invitro-
gen), 1 mM L-glutamine, 0.1 mM non-essential amino acids,
55 mM b-mercaptoethanol and 10 ng/ml bFGF (Joint Protein
Central). In some cases, hES cells were also maintained on Matrigel
(BD Biosciences) using either MEF-conditioned hES medium or
mTeSR1 (Stem Cell Technologies). hES cell colonies were split
using a solution of collagenase (1 mg/ml) or dispase (2 mg/ml) and
scraping the colonies with a glass pipette. Derived hiPS cells were
cultured similarly as described above for hES cells. For differenti-
ation into embryoid bodies (EBs), hES or hiPS cell colonies growing
on MEFs were loosely detached by dispase treatment, resuspended
in EB media (DMEM/F12 supplemented with 10% FBS (Atlanta
Biologicals), 0.5 mM L-glutamine, 0.1 mM non-essential amino
acids and 55 mM b-mercaptoethanol), and maintained on low
attachment plates with daily media changes. 4 days later the floating
EBswereplatedongelatin-coatedplatesandallowedtodifferentiate
for another 10 days in EB media. Similar experiments were
performed using H1 or H9 cell lines. 293T cells were cultured in
DMEM (Invitrogen) supplemented with 10% FBS and 0.1 mM
non-essential aminoacids. Human keratinocytes were obtained and
cultured as described [24]. Human astrocytes isolated from human
cerebellar tissue were obtained from ScienCell Research Labora-
tories. Astrocytes were characterized by immunofluorescence with
antibodies to GFAP, and are able to be expanded for 10 population
doublings, as described by ScienCell Research Laboratories. Two
different cellular batches of astrocytes were used in this study.
IMR90 were obtained from ATCC and cultured in DMEM, 10%
FBS (Atlanta Biologicals) and 0.1 mM non-essential amino acids.
Human hiPS cell generation
For the formation of human hiPS cells, astrocytes, fibroblasts or
keratinocytes were infected with an equal ratio of retroviruses
encoding Oct4, Sox2, Klf4 and cMyc (OSKC) by spinfection of
the cells at 1850 rpm for 1 hour at room temperature in the
presence of polybrene (4 mg/ml). After two infections at day 0 and
day 1, cells were passaged onto fresh MEFs and switched to hES
cell medium at day 4 after the infection. Colonies were stained for
either alkaline phosphatase (AP) or Nanog expression at day 18.
For the derivation of hiPS cells lines, colonies were manually
picked and maintained on fresh MEF feeder layers for 5 passages
before growth in Matrigel/mTesR1 conditions. To calculate the
efficiency of reprogramming, we first evaluated the percentage of
infected cells, based on GFP expression by flow cytometry, and
plated the same number of GFP
+ cells on MEFs after the infection.
Figure 5. ASThiPS cell lines differentiate into Neural Progenitor Cells (NPCs), neurons and astrocytes. Top row panels: hiPS cell-derived
NPCs express Nestin throughout the cytoplasm and Sox2 specifically within the nucleus. Middle row panels: hiPS-derived neurons express the
neuronal marker bIII-tubulin and the dendritic marker MAP2ab. Bottom row panels: hiPS-derived astrocytes express the astrocyte marker GFAP but
not the neuronal marker bIII-tubulin. DAPI was used to visualize the nuclei. Scale bar: 50 mM.
doi:10.1371/journal.pone.0015526.g005
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+ colonies at day 18 was
evaluated by immunohistochemistry.
hiPS differentation to NPCs and Neurons
hiPS cells growing in hES media on MEFs were incubated with
collagenase (1 mg/ml in DMEM) at 37uC for 1–2 hours until
colonies lifted from the plate. Colonies were washed with DMEM,
transferred to a nonadherent plate (Costar) and maintained in
suspension in N2 media (DMEM/F12-Glutamax, 1X N2, Invitro-
gen). After 7 days, EBs were plated in N2 media onto PORN/
Laminin-coated plates. Visible rosettes formed within 1 week and
were manually dissected onto PORN/Laminin-coated plates.
Rosettes were cultured in NPC media (N2 media with 1 mg/ml
laminin and 20 ng/ml FGF-2) and dissociated in Tryple (Gibco) for
3 minutes at 37uC. NPCs were maintained best at high density and
split approximately 1:5 every week. To generate neurons, NPCs
were dissociated with Tryple and plated onto PORN/Laminin-
coated plates in neural differentiation media (DMEM/F12-
Glutamax, 1X B27-RA, 1X N2 with 20 ng/ml BDNF, 20 ng/ml
GDNF (Peprotech), 1 mm dibutyrl-cyclicAMP (Sigma), 200 nm
ascorbic acid (Sigma) at a density of 50,000 cells per well of a 4-well
permanox slide. Neurons were analyzed following one month of
differentiation of NPCs in neural differentiation media.
Flow cytometry analysis
For BrdU detection, cells were incubated with hES cell media or
mTeSR1 containing 10 mM BrdU for 30 minutes. Cells were
individualized using TrypLE Express (Invitrogen) 1:4 in PBS
(Calcium
2/Magnesium
2) and fixed in 70% ethanol overnight.
The cell pellet was resuspended in cold 0.1 M HCl/0.5%
TritonX-100 for 10 minutes, after which the cells were boiled
for 10 minutes in a water bath and transferred to ice for 5 minutes
to cool. After a brief incubation in 0.5% Triton-X100 in PBS, cells
were incubated with a rat-antiBrdU antibody (1:100 dilution;
Axyll) for 30 minutes followed by incubation with an Alexa-Fluor
488 goat anti-rat secondary antibody (Invitrogen) for 20 minutes.
The cell pellet was resuspended in PBS containing 5 mg/ml of
propidium iodide and 100 mg/ml of RNaseA. Flow cytometry
analyses were conducted using a FACScan (BD Bioscience) and
data was analyzed using FlowJo and WinMDI 2.8 software.
RNA isolation and real time-PCR analysis
Total RNA was isolated using Trizol Reagent (Invitrogen)
according to the manufacturer’s recommendations, and cDNA
synthesized using the SuperScript II Reverse Transcriptase kit for
RT-PCR (Invitrogen). Real-time PCR was performed using the
SYBR-Green PCR Master mix (Applied Biosystems). Values of
gene expression were normalized using GAPDH expression and
are shown as fold change relative to the value of the sample
control. All the samples were done in triplicate. A list of the
primers used for real time-PCR experiments are listed in Tables
S1 and S2. Primers of the genes selected for the described stem cell
array were based on the Human Stem RT2 Cell Array (Super-
Array Biosciences Corporation) including genes involved in self-
renewal, cell cycle, chromosome and chromatin modulators,
cytokines and growth factors, cell communication and adhesion,
metabolic markers, stem cell maintenance or asymmetric division
as well as the expression of the reprogramming genes. For a
complete list of the genes see Table S1.
Plamids
pMX-Oct4, pMX-SOX2, pMX-KLF4 and pMX-cMyc were
obtained from Addgene (plasmids 17217, 17218, 17219 and 17220
respectively). pMX-eGFP was kindly provided by Dr. Teruhisa
Kawamura (Gene Expression Laboratory, The Salk Institute, La
Jolla, CA).
Retroviral production
Moloney-based retroviral vectors (pMX-) were co-transfected
with packaging plasmids (pCMV-gag-pol-PA and pCMV-VSVg,
kindly provided by Dr. Gerald Pao, Laboratory of Genetics, The
Salk Institute, La Jolla, CA) in 293T cells using Lipofectamine
(Invitrogen). Retroviral supernatants were collected 24 and
48 hours after transfection, pooled and passed through a
0.45 mM filter to remove cellular debris.
Immunostainings
For the immunohistochemical detection of Nanog, cells were
fixed with 4% formaldehyde in PBS for 15 minutes, washed with
PBS and incubated with 0.5% Triton-X100 in PBS for 10
minutes. A rabbit anti-hNanog (1:500) in 1% PBS-BSA was used
for overnight incubation at 4uC followed by incubation with a
secondary biotin-conjugated anti-rabbit antibody (1:2000) for an
additional 2 hours at room temperature (RT). Cells were then
incubated with streptavidin-HRP (Vector, 1:1000) and a DAB
substrate kit for peroxidase (Vector, SK-4100) was used to develop
the staining. For standard immunofluorescence, cells were fixed
with 4% paraformaldehyde in PBS for 15 minutes, washed in PBS
incubated with 0.5% Triton-X100 in PBS for 10 minutes and
blocked with 5% normal donkey serum in 1% PBS-BSA for
1 hour at RT. Antibodies in 1% PBS-BSA (see Table S3 for
details) were used for overnight incubation followed by incubation
with a secondary AlexaFluor 488 or 568 (Invitrogen) for an
additional 2 hours at room temperature. DAPI was used to
visualize nuclei at a concentration of 10 mg/ml in PBS.
Karyotype analysis
hiPS cell lines grown on Matrigel were cultured in the presence
of 20 ng/ml of colcemid for 45 minutes. The cells were
trypsinized, washed with PBS and resuspended in a hypotonic
solution by drop-wise addition while vortexing at low speed. After
10 minutes of incubation at 37uC, cells were fixed by drop-wise
addition of 1 ml of cold Carnoy fixative. Stained metaphases were
analyzed with Cytovision software (Applied Imaging).
Teratoma formation
Severe combined immunodeficient (NOD.Cg-Prkdc
scid
Il2rg
tm1Wjl/SzJ; Jackson Laboratories) wereused to testthe teratoma
induction capacity of the iPS cell lines. Briefly, ,10
6 iPS cells in
,50 mL of hES cell medium were injected into the testis or kidney
capsule of anesthetized mice. Mice were monitored for teratoma
formation and euthanized ,6–12 weeks after injection. Teratomas
were processed and analyzed by hematoxylin and eosin staining
and conventional immunofluorescence. All animal experiments
were performed and approved (accepted protocol number 08-025)
in full accordance of The Salk Institute Institutional Animal Care
and Use Committee (IACUC) guidelines.
Western blot analysis
Cell pellets were lysed in 10 mM Tris-HCl (pH 8), 150 mM
NaCl, 1% Triton X100, 1 mM Na3VO4, 1 mM PMSF and the
Cømplete protease inhibitor mixture (Roche). Total protein
extracts (25 mg) were used for SDS-PAGE, transferred to
nitrocellulose membranes (Amersham Biosciences) and analyzed
using primary antibodies (see Table S3 for details). Horseradish
peroxidase-conjugated secondary anti-mouse or rabbit were
Somatic Cell Reprogramming of Human Astrocytes
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Tubulin was used as a loading control. Immunoblots were
visualized using SuperSignal solutions following the manufactur-
er’s instructions (Thermo Scientific).
Alkaline phosphatase (AP) staining
For AP staining, cells were fixed in a solution of 4%
paraformaldehyde in PBS for 20 minutes. After extensive washes
in PBS, cells were incubated in NTMT solution (10 mM NaCl,
100 mM Tris-HCl (pH 9), 50 mM MgCl2 and 0.1% Tween-20)
for 5 minutes and then in NTMT solution supplemented with
NBT (Nitro-Blue Tetrazolium Chloride) and BCIP (5-Bromo-4-
Chloro-3’-Indolyphosphate p-Toluidine Salt) in the dark until the
staining developed.
Statistical analysis
Results are reported as an average 6 SEM (see figure legends
for specific details regarding the number of biological replicates,
independent experiments and technical replicates). Statistics were
performed using two-tailed T-student analyses. Values with
p,0.05 were considered statistically significant. The values
obtained from the stem cell array were clustered using a Pearson
Correlation.
Supporting Information
Table S1 Forward and reverse sequence of the primers used for
the described stem cell array which include genes involved in self-
renewal, cell cycle, chromosome and chromatin modulators,
cytokines and growth factors, cell communication and adhesion,
metabolic markers, stem cell maintenance or asymmetric division
as well as the expression of the reprogramming genes.
(DOC)
Table S2 Forward and reverse sequence of the primers used in
this study to analyze the expression of pluripotent genes,
differentiation markers and cell cycle regulators.
(DOC)
Table S3 List of the antibodies used in this study. IF: Immuno-
fluorescence. WB: Western Blot. Flow Cyt: Flow Cytometry.
(DOC)
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